These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33778950)

  • 1. The value of C-reactive protein-to-albumin ratio in predicting long-term mortality among HFrEF patients with implantable cardiac defibrillators.
    Çinier G; Hayıroğlu Mİ; Kolak Z; Tezen O; Yumurtaş AÇ; Pay L; Eren S; Çetin T; Özcan S; Türkkan C; Özbilgin N; Tekkeşin Aİ; Alper AT; Gürkan K
    Eur J Clin Invest; 2021 Aug; 51(8):e13550. PubMed ID: 33778950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic nutritional index as the predictor of long-term mortality among HFrEF patients with ICD.
    Çinier G; Hayıroğlu Mİ; Pay L; Yumurtaş AÇ; Tezen O; Eren S; Kolak Z; Çetin T; Özcan S; Türkkan C; Özbilgin N; Tekkeşin Aİ; Alper AT; Gürkan K
    Pacing Clin Electrophysiol; 2021 Mar; 44(3):490-496. PubMed ID: 33438766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Optimization of Medical Treatment on Long-Term Survival of Patients With Heart Failure After Implantable Cardioverter Defibrillator and Cardiac Resynchronization Device Implantation (from the French National EGB Database).
    Massoullié G; Chouki C; Mulliez A; Rossignol P; Ploux S; Pereira B; Reuillard A; Jean F; Andronache M; Eschalier A; Motreff P; Clerfond G; Bordachar P; Authier N; Eschalier R
    Am J Cardiol; 2018 Mar; 121(6):725-730. PubMed ID: 29402420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for early mortality in patients with implantable cardiac defibrillator for heart failure with reduced ejection fraction.
    Çinier G; Hayıroğlu Mİ; Çınar T; Pay L; Yumurtaş AÇ; Tezen O; Eren S; Kolak Z; Çetin T; Özcan S; Türkkan C; Özbilgin N; Tekkeşin Aİ; Alper AT; Gürkan K
    Indian Heart J; 2022; 74(2):127-130. PubMed ID: 35104458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response association of implantable device-measured physical activity with long-term cardiac death and all-cause mortality in patients at high risk of sudden cardiac death: a cohort study.
    Li X; Zhao S; Chen K; Hua W; Su Y; Yang J; Liang Z; Xu W; Zhang S
    Int J Behav Nutr Phys Act; 2020 Sep; 17(1):119. PubMed ID: 32957993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only.
    Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F
    Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate turbulence predicts ICD-resistant mortality in ischaemic heart disease.
    Marynissen T; Floré V; Heidbuchel H; Nuyens D; Ector J; Willems R
    Europace; 2014 Jul; 16(7):1069-77. PubMed ID: 24196450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
    Çınar T; Çağdaş M; Rencüzoğulları İ; Karakoyun S; Karabağ Y; Yesin M; Sadioğlu Çağdaş Ö; Tanboğa Hİ
    Scand Cardiovasc J; 2019 Apr; 53(2):83-90. PubMed ID: 30835559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
    Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death.
    Amara N; Boveda S; Defaye P; Klug D; Treguer F; Amet D; Perier MC; Gras D; Algalarrondo V; Bouzeman A; Piot O; Deharo JC; Fauchier L; Babuty D; Bordachar P; Sadoul N; Marijon E; Leclercq C;
    Europace; 2018 Jan; 20(1):65-72. PubMed ID: 28082419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus.
    Sharma A; Wu J; Xu H; Hernandez A; Felker GM; Al-Khatib S; Green J; Matsouaka R; Fonarow GC; Singh JP; Heidenreich PA; Ezekowitz JA; DeVore A
    J Am Heart Assoc; 2020 Jun; 9(12):e012405. PubMed ID: 32476539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction.
    Jilek C; Lewalter T; Pauschinger M; von Scheidt W; Frankenstein L; Pfister O; Hambrecht R; Bruder O; Brachmann J; Hartmann A; Strasser R; Hochadel M; Senges J
    Clin Res Cardiol; 2020 Jan; 109(1):115-123. PubMed ID: 31236690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Benefit of Prophylactic Implantable Cardioverter Defibrillator Implantation in Asymptomatic Heart Failure Patients With a Reduced Ejection Fraction.
    van der Lingen ACJ; Timmer SAJ; Allaart LJH; Rijnierse MT; van de Ven PM; van Rossum AC; Kemme MJB; van Halm VP; Allaart CP
    Am J Cardiol; 2019 Aug; 124(4):560-566. PubMed ID: 31270031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trial.
    Lee TC; Qian M; Mu L; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Lip GYH; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    ESC Heart Fail; 2019 Apr; 6(2):297-307. PubMed ID: 30816013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.
    Adabag S; Patton KK; Buxton AE; Rector TS; Ensrud KE; Vakil K; Levy WC; Poole JE
    JAMA Cardiol; 2017 Jul; 2(7):767-774. PubMed ID: 28724134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM; Holzmeister J; Hübler M; Hübler S; Wolfrum M; Enseleit F; Seifert B; Hürlimann D; Lehmkuhl HB; Noll G; Steffel J; Falk V; Lüscher TF; Hetzer R; Ruschitzka F
    Heart; 2013 Aug; 99(16):1158-65. PubMed ID: 23813845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
    Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
    Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Risk Versus Predicting Potential Survival Benefit Using 123I-mIBG Imaging in Patients With Systolic Dysfunction Eligible for Implantable Cardiac Defibrillator Implantation: Analysis of Data From the Prospective ADMIRE-HF Study.
    Hachamovitch R; Nutter B; Menon V; Cerqueira MD
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26666380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.